Long-term Activity Coaching in Patients With COPD
The Long-term Effects of a Tele Coaching Intervention in Patients With COPD: a Randomized Controlled Trial
1 other identifier
interventional
150
1 country
2
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of mortality and morbidity around the world. Studies revealed that patients with COPD are less active than age-matched healthy controls and activity level decreases with disease severity. Higher levels of physical activity is related to important health-related outcomes, such as lower mortality rate and hospital admissions. Additionally, increasing physical activity is related with substantial health benefits. Patients with COPD have a higher risk of developing insulin resistance, hypertension, dyslipidemia, osteopenia, leading to chronic diseases such as coronary heart disease, type 2 diabetes and osteoporosis, which have been related to physical inactivity in the healthy population. Moreover, physical inactivity has been related to the occurrence of comorbidities in patients with COPD. Therefore, improving physical activity levels is a recommended treatment in the disease management in all patients with COPD and is implemented in the recent GOLD guidelines for all patients with COPD, regardless of the disease severity. The research group investigated the effect of a 3-month semi-automatic tele-coaching intervention on physical activity levels in patients with COPD. The tele coaching intervention led to a significant improvement on physical activity in the intervention group. Although this trial showed positive results on physical activity, further research is needed, mainly to investigate the long-term (12 months) effectiveness of such interventions and the added value of a smartphone application on top of a simple step counter providing feedback. Additionally, since physical activity is related to the development of comorbidities, the investigators aim to explore the influence of improving physical activity levels on the occurrence of cardiovascular, metabolic and musculoskeletal comorbidities. Finally, this study will explore baseline characteristics (such as social support, self-efficacy, dynamic hyperinflation, etc.) that can predict success in this intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2019
CompletedFirst Posted
Study publicly available on registry
October 25, 2019
CompletedStudy Start
First participant enrolled
January 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 11, 2023
CompletedJanuary 19, 2024
January 1, 2024
3.9 years
October 23, 2019
January 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Daily number of steps at 12 months
Change in daily mean step count 12 months post randomization in the intervention group as compared to the control group. Physical activity will be objectively measured for 1 week using a tri-axial accelerometer validated for use in patients with COPD. At least 4 valid weekdays (\> 8 hours of wearing time during waking hours) is necessary to label the physical activity measurement as valid.
12 months
Secondary Outcomes (14)
Daily number of steps at 6 months
6 months
Minutes per day spent in at least moderate intense activities
6 months and 12 months
Mean walking time per day
6 months and 12 months
Mean sedentary time per day
6 months and 12 months
Exercise capacity
6 months and 12 months
- +9 more secondary outcomes
Study Arms (2)
Type 1 tele coaching group
EXPERIMENTALCoaching with daily interaction with the coaching application, based on a adaptive physical activity goal
Type 2 tele coaching group
SHAM COMPARATORCoaching with fixed physical activity goal and limited interaction with the smartphone application
Interventions
A) Education about the importance of PA. During a one-to-one interview with the coach motivation, self-efficacy, barriers, favorite activities and strategies to become more active are discussed. B) Step counter providing direct feedback. C) A smartphone with a project-tailored application. The application provides automated coaching by displaying an activity goal (number of steps) and feedback on a daily basis. The feedback comes with a graphical presentation. Patients' targets are automatically revised weekly. The aim is to progressively increase the PA during the 12 weeks period and maintain afterwards. D) Telephone contacts triggered in the case of non-compliance with wearing the step counter, failure to transmit data, failure to progress or change in medication. Coaches are alerted by a note at the coaches' backend to take contact with the patient if needed.
A) Education about the importance of PA. During a one-to-one interview with the investigator, patients will receive a personal goal (expressed in steps/day), based on their individual exercise capacity. B) A step counter providing direct feedback. C) A smartphone with a project-tailored application. The application receives the step data of the patient and asks on a weekly basis about the patient's change in medication. The application does provide a graph showing the steps the patient took and presents a general activity plan including their personal goal (which stays the same throughout the entire intervention period). D) Telephone contacts triggered in the case of change in medication. Coaches are alerted by a note at the coaches' backend to take contact with the patient if needed.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with COPD (GOLD criteria post bronchodilator FEV1/FVC \< 0.70)
- Patients under medical follow-up of a respiratory physician or general practitioner with no moderate (ambulatory treated) and/or severe (requiring a hospital admission) exacerbation in the past month
- Older than 40 years old
- Smoking history with more than 10 pack years
You may not qualify if:
- The presence of orthopedic or other problems not allowing an increase in physical activity levels
- Unable to learn to work with a new electronic device (e.g. smartphone), as judged by the investigator
- Underwent lung transplantation or active on the lung transplantation list
- Involved in or planned to start with a structured multidisciplinary rehabilitation program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
- University Ghentcollaborator
Study Sites (2)
UZ Gent
Ghent, Belgium
UZ Leuven
Leuven, 3000, Belgium
Related Publications (1)
Blondeel A, Hermans F, Breuls S, Wuyts M, Everaerts S, De Maeyer N, Derom E, Janssens W, Demeyer H, Troosters T. A Long-Term Physical Activity Coaching Program for Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Am J Respir Crit Care Med. 2025 Dec;211(12):2330-2339. doi: 10.1164/rccm.202501-0170OC.
PMID: 40700740DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wim Janssens, Prof
KU Leuven
- PRINCIPAL INVESTIGATOR
Heleen Demeyer, Dr
KU Leuven
- PRINCIPAL INVESTIGATOR
Thierry Troosters, Prof
KU Leuven
- PRINCIPAL INVESTIGATOR
Nikolaas De Maeyer, Dr
UZ Leuven
- PRINCIPAL INVESTIGATOR
Astrid Blondeel
KU Leuven
- PRINCIPAL INVESTIGATOR
Eric Derom, Prof.Dr.
UZ Gent
- PRINCIPAL INVESTIGATOR
Fien Hermans
U Gent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients in the control group will receive a sham version of the smartphone application. Patients are unaware of the difference between the coaching programs.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 23, 2019
First Posted
October 25, 2019
Study Start
January 22, 2020
Primary Completion
December 11, 2023
Study Completion
December 11, 2023
Last Updated
January 19, 2024
Record last verified: 2024-01